{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:36:34Z","timestamp":1787160994485,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016109","name":"Taishan Industry Leading Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijbiomac.2026.153337","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:32:25Z","timestamp":1782948745000},"page":"153337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Molecular interactions and viscosity regulation mechanism of IgG4 antibody in high-concentration solutions"],"prefix":"10.1016","volume":"374","author":[{"given":"Yan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.153337_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148607","article-title":"Emerging trends and therapeutic applications of monoclonal antibody therapy","volume":"925","author":"Mekala","year":"2024","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.153337_bb0010","article-title":"A comprehensive review of monoclonal antibodies in modern medicine: tracing the evolution of a revolutionary therapeutic approach","volume":"16","author":"Kothari","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115301","article-title":"Towards more tolerable subcutaneous administration: review of contributing factors for improving combination product design","volume":"209","author":"Mathias","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.153337_bb0020","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12551-025-01346-2","article-title":"Development of high-concentration monoclonal antibody formulations for subcutaneous administration to improve patient treatment","volume":"17","author":"Mijangos","year":"2025","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2017.06.029","article-title":"High-concentration protein formulations: how high is high?","volume":"119","author":"Garidel","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0030","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","article-title":"Challenges in the development of high-protein-concentration formulations","volume":"93","author":"Shire","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12247-019-09414-3","article-title":"Challenges and considerations in development and manufacturing of high concentration biologics drug products","volume":"15","author":"Sahin","year":"2020","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103877","article-title":"Current and emerging strategies for subcutaneous delivery of high-concentration and high-dose antibody therapeutics","volume":"114","author":"Ren","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0045","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcis.2020.06.105","article-title":"Control of viscosity in biopharmaceutical protein formulations","volume":"580","author":"Zidar","year":"2020","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0050","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1021\/acs.molpharmaceut.0c00552","article-title":"Temperature dependence of protein solution viscosity and protein\u2013protein interactions: insights into the origins of high-viscosity protein solutions","volume":"17","author":"Woldeyes","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0055","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.xphs.2019.03.008","article-title":"Enhancing stability and reducing viscosity of a monoclonal antibody with cosolutes by weakening protein-protein interactions","volume":"108","author":"Dear","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0060","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jps.22831","article-title":"Viscosity behavior of high-concentration monoclonal antibody solutions: correlation with interaction parameter and electroviscous effects","volume":"101","author":"Yadav","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0065","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.addr.2006.03.011","article-title":"Formulation and delivery issues for monoclonal antibody therapeutics","volume":"58","author":"Daugherty","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0070","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1021\/mp5002334","article-title":"The role of electrostatics in protein\u2013protein interactions of a monoclonal antibody","volume":"11","author":"Roberts","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0075","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/mp500485w","article-title":"Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations","volume":"12","author":"Buck","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0080","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1021\/acs.molpharmaceut.5b00643","article-title":"Viscosity-lowering effect of amino acids and salts on highly concentrated solutions of two IgG1 monoclonal antibodies","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0085","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2011.09.017","article-title":"Impact of short-range hydrophobic interactions and long-range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations","volume":"421","author":"Kumar","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0090","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.xphs.2022.05.011","article-title":"Viscosity reduction and stability enhancement of monoclonal antibody formulations using derivatives of amino acids","volume":"111","author":"Srivastava","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11095-016-2055-5","article-title":"Contrasting the influence of cationic amino acids on the viscosity and stability of a highly concentrated monoclonal antibody","volume":"34","author":"Dear","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2022.108055","article-title":"Ionic liquids as protein stabilizers for biological and biomedical applications: a review","volume":"61","author":"Ver\u00edssimo","year":"2022","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114295","article-title":"Ultra-high concentration low-viscosity subcutaneous antibody formulations using ionic liquids","volume":"388","author":"Ramesh","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/abt\/tbad022","article-title":"Effects of arginine in therapeutic protein formulations: a decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antibody Therapeut."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/mp5000218","article-title":"Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations","volume":"11","author":"Inoue","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0120","article-title":"Protein-protein interactions at high concentrations: effects of ArgHCl and NaCl on the stability, viscosity and aggregation mechanisms of protein solution","volume":"601","author":"Y","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0125","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.xphs.2020.12.016","article-title":"Product-specific impact of viscosity modulating formulation excipients during ultra-high concentration biotherapeutics drug product development","volume":"110","author":"Rodrigues","year":"2021","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.153337_bb0130","doi-asserted-by":"crossref","DOI":"10.2174\/1871527322666230306085937","article-title":"Comprehensive perspective towards the management of proteinopathies by elucidating protein misfolding and aggregation","volume":"23","author":"Ahanger","year":"2024","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0135","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1021\/acs.molpharmaceut.3c00440","article-title":"Biophysical determinants for the viscosity of concentrated monoclonal antibody solutions","volume":"20","author":"Mosca","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2024.2379560","article-title":"Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated fc mutations","volume":"16","author":"Heisler","year":"2024","journal-title":"mAbs"},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0145","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1021\/acs.molpharmaceut.3c01075","article-title":"Quantifying protein shape to elucidate its influence on solution viscosity in high-concentration electrolyte solutions","volume":"21","author":"Tian","year":"2024","journal-title":"Mol. Pharm."},{"issue":"43","key":"10.1016\/j.ijbiomac.2026.153337_bb0150","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/acs.iecr.6b02042","article-title":"Viscosity reduction of a concentrated monoclonal antibody with arginine\u00b7HCl and arginine\u00b7glutamate","volume":"55","author":"Borwankar","year":"2016","journal-title":"Ind. Eng. Chem. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.153337_bb0155","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1021\/acsomega.0c05638","article-title":"Heparin accelerates the protein aggregation via the downhill polymerization mechanism: multi-spectroscopic studies to delineate the implications on proteinopathies","volume":"6","author":"Ahanger","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.636454","article-title":"Rationalizing the role of monosodium glutamate in the protein aggregation through biophysical approaches: potential impact on neurodegeneration","volume":"15","author":"Ahanger","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0165","doi-asserted-by":"crossref","first-page":"000","DOI":"10.1016\/j.molliq.2025.127626","article-title":"Impact of amino acid derivative osmolytes on structure-function integrity and aggregation propensity of catalase: implications for inefficient antioxidant defense in protein aggregation disorders","volume":"429","author":"Manzoor","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijbiomac.2026.153337_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141054","article-title":"Neurometabolite, myo-inositol, induces conformational distortion with enhanced aggregation of carbonic anhydrase: implications for altered metabolite levels in Alzheimer\u2019s disease","volume":"1325","author":"Ahanger","year":"2025","journal-title":"J. Mol. Struct."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026032770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026032770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:34:45Z","timestamp":1787157285000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026032770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"alternative-id":["S0141813026032770"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153337","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular interactions and viscosity regulation mechanism of IgG4 antibody in high-concentration solutions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153337"}}